Skip to main content
Log in

The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction

  • Peritoneal Surface Malignancy
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of peritoneal surface malignancies of various causes. These guidelines are developed with input from leading experts including surgical oncologists, medical oncologists, pathologists, radiologists, palliative care physicians, and pharmacists. These guidelines recognize and address the emerging need for increased awareness of the appropriate management of peritoneal surface disease. They are not intended to replace the quest for higher levels of evidence. This article serves as an introduction to this effort.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Acknowledgment

Collaborators: Kiran Turaga, MD, MPH, University of Chicago, Department of Surgery, Chicago, IL; Nita Ahuja, MD, MBA, Yale University, Surgery, New Haven, CT; H. Richard Alexander Jr., MD, Rutgers Cancer Institute of New Jersey, Division of Surgical Oncology, New Brunswick, NJ; Daniel E. Abbott, MD, University of Wisconsin, Department of Surgery, Madison, WI; Brian Badgwell, MD, MS, MD Anderson Cancer Center, Surgical Oncology, Houston, TX; Joel M. Baumgartner, MD, MAS, UC San Diego Health, Surgery, La Jolla, CA; M. Haroon A. Choudry, MD, University of Pittsburgh, Surgery, Surgical Oncology, Pittsburgh, PA; James C. Cusack Jr, MD, Massachusetts General Hospital, Department of Surgery, Boston, MA; Jeremiah L. Deneve, DO, University of Tennessee Health Science Center, Surgery, Memphis, TN; Jesus Esquivel, MD, Frederick Memorial Hospital, Surgical Oncology, Frederick, MD; Jason M. Foster, MD, University of Nebraska/Nebraska Medicine, Surgery, Division of Surgical Oncology, Omaha, NE; Nader Hanna, MD, FACS, University of Maryland School of Medicine, Surgery, Baltimore, MD; Andrea Hayes-Jordan, MD, FACS, FAAP, University of North Carolina School of Medicine, Department of Surgery, Division of Pediatric Surgery, Chapel Hill, NC; Fabian M. Johnston, MD, MHS, Johns Hopkins University, Surgery, Baltimore, MD; Daniel M Labow, MD, Icahn School of Medicine at Mount Sinai, Department of Surgery, New York, NY; Laura A. Lambert, MD, Huntsman Cancer Institute/University of Utah, General Surgery, Salt Lake City, UT; Byrne Lee, MD, City of Hope, Division of Surgical Oncology, Duarte, CA; Edward A. Levine, MD, Wake Forest Baptist Health, Surgical Oncology, Winston-Salem, NC; Andrew M. Lowy, MD, UC San Diego Health, Department of Surgery, La Jolla, CA; Garrett M. Nash, MD, MPH, Memorial Sloan Kettering Cancer Center, Surgery, New York, NY; Charles Staley, MD, Emory University School of Medicine, Department of Surgery, Atlanta, GA; Konstantinos I. Votanopoulos, MD, PhD, Wake Forest Baptist Health, Surgery, Winston-Salem, NC; Maheswari Senthil, MD, Loma Linda University Health, Surgical Oncology, Loma Linda, CA; Paul H. Sugarbaker, MD, MedStar Washington Hospital Center, Washington, DC; S. Diane Yamada, MD, University of Chicago Medicine, Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Chicago, IL; David L. Bartlett, MD, University of Pittsburgh, Surgery, Pittsburgh, PA.

Funding

The Irving Harris Foundation and the University of Chicago.

Author information

Authors and Affiliations

Consortia

Ethics declarations

Disclosures

Nita Ahuja reports grant funding from Cepheid and Astex, has served as a consultant to Ethicon, and has licensed methylation biomarkers to Cepheid. James C. Cusack reports grants from Lumicell Inc. outside the submitted work. Jesus Esquivel reports personal fees from Eight Medical. Garrett M. Nash reports non-financial support from Intuitive outside the submitted work. The remaining authors disclosed no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The collaborators for the Chicago Consensus Working Group are listed in the acknowledgments.

Correspondence to: K. Turaga, MD

Department of Surgery, University of Chicago, Chicago, IL

e-mail: kturaga@surgery.bsd.uchicago.edu

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chicago Consensus Working Group. The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction. Ann Surg Oncol 27, 1737–1740 (2020). https://doi.org/10.1245/s10434-020-08318-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08318-8

Navigation